Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score
Version of Record online: 25 FEB 2014
© 2014 John Wiley & Sons Ltd
Journal of Viral Hepatitis
Volume 21, Issue 9, pages e98–e107, September 2014
How to Cite
Virlogeux, V., Pradat, P., Bailly, F., Funingana, G., Gonçalves, F., Maynard, M., Hartig-Lavie, K., Amiri, M. and Zoulim, F. (2014), Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score. Journal of Viral Hepatitis, 21: e98–e107. doi: 10.1111/jvh.12237
- Issue online: 1 AUG 2014
- Version of Record online: 25 FEB 2014
- Manuscript Accepted: 17 DEC 2013
- Manuscript Received: 5 SEP 2013
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.